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The world's ®rst case of Serratia liquefaciens intravascular
catheter-related suppurative thrombophlebitis and native
valve endocarditis
Serratia liquefaciens is an organism rarely encountered in clinical
practice. Itbelongs to thegenusSerratia and the familyEnterobac-
teriaceae [1]. It is widely distributed in nature, including river
water [2], mineral, spring and table water [3], domestic sewage
[4], ¢sh, minced meat and pasteurized milk or cream [5]. It has
been reported as a cause of mastitis in a dairy herd [6]. In
humans, it has rarely been reported as a cause of nosocomial
infections, including urinary tract infection [7], pneumonia
[8], post-sternotomymediastinitis [9], neonatalmeningitis [10]
and septicaemia resulting from transfusion of contaminated
blood products [11]. A few reports of S. liquefaciens causing
community-acquired infections include peritonitis associated
with continuous ambulatoryperitoneal dialysis [12], pustulosis
and costochondritis in heroin addicts [13], ¢stulous pyoderma
[14], septic arthritis [15] and ocular infections resulting from
contaminationofcontact lens cases [16].
I recently encountered a patient who developed an intravas-
cular central catheter-related suppurative thrombophlebitis
and endocarditis due to S. liquefaciens. He was a 55-year-old
manwho had developed short gut syndrome as a complication
of chronic pancreatitis and multiple bowel resections. He had
been dependent on parenteral nutrition for the preceding 6
months. He presentedwith fever, malaise and pain in the right
side of the neck, along the tunnel of the indwelling intrave-
nous central catheter. On physical examination, he had no
heart murmur or peripheral signs of endocarditis. Four blood
cultures grew S. liquefacienswithin 48 h of inoculation. Duplex
ultrasound revealed an occlusive clot in the right internal
jugular vein surrounding the central venous catheter. Transe-
sophageal echocardiography showed a mobile thrombus ori-
ginating in the superior vena cava extending into the right
atrium, measuring 5.2 0.9 cm, and all heart valves appeared
normal. After a therapeutic anticoagulation was achieved, the
central venous catheter was removed. He subsequently under-
went resection of the right atrial mass, which on histological
examination was con¢rmed to be a thrombus with secondary
suppurative endocarditis. The organism was susceptible to
multiple antibiotics, including piperacillin, trimethoprim-
sulfamethoxasole, third-generation cephalosporins, cipro£ox-
acin and imipenem-cilastatin. He was treated with ceftriax-
one, 2 g daily for 4weeks, for ease of administration with
concomitant parenteral nutrition.
To date, there have been no prior reports of suppurative
thrombophlebitis or endocarditis caused by S. liquefaciens in
the world's literature. This organism is di¡erentiated from S.
marcescens by its relatively weak phospholipase activity [17] and
the lack of fermentation of L-arabinose by the latter [1]. Anti-
microbial susceptibility is also somewhat di¡erent, with S.
liquefaciens being more resistant to aztreonam, ceftazidime and
amikacin than S.marcescens [18].
Endocarditis caused by S.marcescens is seen most commonly
in intravenous drug users and in one report it caused14% of all
addict-associated endocarditis [19]. Among these patients,
most cases of right-sided endocarditis were cured by antibio-
tics alone and most cases of left-sided endocarditis treated
medically did not survive. Most other cases of endocarditis
due to S. marcescens have occured in patients with prosthetic
heart valves. Only two cases of native valve endocarditis due
to S. marcescens were reported in the literature [20,21]. Both
had right-sided involvement and indwelling intravenous
catheters at the time of diagnosis and both were successfully
treated medically. An experimental endocarditis rabbit model
using S. marcescens con¢rmed the signi¢cance of the presence
of an indwelling catheter in the development of endocarditis
[22].
The classic presentation of suppurative thrombophlebitis
involves the internal jugular vein in association with acute
oropharyngeal infections ^ Lemierre's syndrome. However,
several other veins can be a¡ected by the same problem, such
as the pelvic veins with puerperal sepsis, the portal vein with
in£ammatory bowel disease and the dural venous sinuses with
contiguous infections. Suppurative thrombophlebitis of the
central veins as a complication of central venous catheters is a
common problem in patients receiving cancer chemotherapy
or hyperalimentation. Unlike peripheral vein suppuration,
surgical excision of central veins may not be feasible. Medical
management with intravenous antibiotics, catheter removal
and anticoagulation is a reasonable alternative, but in cases
such as ours, surgical excision of a deep-seated focus of infec-
tion is recommended [23].
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Pericarditis caused by Corynebacterium urealyticum
Corynebacterium urealyticum, formerly known as Corynebacterium
group D2 or CDC group D2 [1], is an aerobic, catalase-posi-
tive, Gram-positive bacillus which shows resistance to multi-
ple antibiotics. It has been associated mainly with infections of
the urinary tract [2], and the isolation of this organism in
other infections is very unusual.We report the ¢rst case, to our
knowledge, in which C. urealyticum is associated with pericar-
ditis.
A 55-year-old woman with a medical history of diabetes
mellitus was admitted to the emergency roomwith a 2-week
history of lower retrosternal pain and dyspnea. On examina-
tion she was pyrexial (38 C) and tachypneic. There were no
pericardial or pleural rubs.The patientwas alert and orientated.
Results of laboratory studies were as follows: hemoglobin
level, 10.4 g/dL; white blood cell count, 9910/mm3 (79% neu-
trophils, 13% lymphocytes, 6.9% monocytes and 0.9% eosi-
nophils); erythrocyte sedimentation rate, 56mm/h. The urea
and electrolyte values were normal. The plasma glucose was
elevated at 296mg/dL. The electrocardiogram (ECG) and
chest X-ray were normal.Two-dimensional echocardiograms
revealedmild cardiomegalywith normalmyocardial contract-
ibility, and a big pericardial e¡usion with ¢brinous bands; no
echocardiographic signs of cardiac tamponade were observed.
Adiagnosis of acute pericarditiswasmade, and pericardiocent-
esis was prescribed. Seven hundred milliliters of a purulent
pericardial £uid were obtained. Histologic examination and
Gram stain of the £uid only showedmany polymorphonuclear
cells. Cultures were performed on blood and chocolate agar,
McConkey agar, Sabouraud agar and Brucella agar. An aero-
bic, catalase-positive bacillus with the typical appearance of
diphtheroids grew in pure culture in blood and chocolate agar.
The organism was initially identi¢ed as C. urealyticum by the
API Coryne System (BioMerieux, Mazcy l'Etoile, France).
Conventional methods of identi¢cation con¢rmed that the
organism was C. urealyticum [1]. The isolate was characterized
by the strong urease activity and the inability to ferment glu-
cose or reduce nitrate. Antimicrobial susceptibility tests were
performed by the Kirby^Bauer disk di¡usion method on
Mueller^Hinton agar with 5% sheep blood. The organism
was susceptible to rifampicin, teicoplanin and vancomycin,
and resistant to penicillin, imipenem, gentamicin, erythromy-
cin and cipro£oxacin.After treatmentwith intravenous vanco-
mycin for 2 weeks, the patient made a rapid and full recovery.
An echocardiogram on day 15 of admission was normal, with
no evidence of pericardial e¡usion.The blood cultures as well
as the urine cultureswere repeatedly negative. Investigation for
mycobacteria, fungi andviruseswas negative.
C. urealyticum has been reported to frequently colonize the
skin of hospitalized patients [3]. Despite frequent coloniza-
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